Description |
xxi, 499 pages : illustrations ; 28 cm |
Bibliography |
Includes bibliographical references. |
Contents |
Chapter 1 How should opioids be started and titrated in routine outpatient settings? -- Chapter 2 How should opioids be started and titrated in hospital or inpatient settings? -- Chapter 3 How should patient-controlled analgesia be used in patients with serious illness and those experiencing postoperative pain? -- Chapter 4 How should opioids be used to manage pain emergencies? -- Chapter 5 What principles should guide oral, transcutaneous, and intravenous opioid dose conversions? -- Chapter 6 Which opioids are safest and most effective in renal failure? -- Chapter 7 How should methadone be started and titrated in opioid naïve and opioid-tolerant patients? -- Chapter 8 What special considerations should guide the safe use of methadone? |
|
Chapter 9 When should corticosteroids be used to manage pain? -- Chapter 10 When should nonsteroidal antiinflammatory drugs be used to manage pain? -- Chapter 11 What is Neuropathic Pain? How do opoids and nonopoids compare for neuropathic pain management? -- Chapter 12 Should bisphosphonates be used routinely to manage pain and skeletal complications in cancer? -- Chapter 13 Should bisphosphonates be used routinely to manage pain and skeletal complications in other conditions? -- Chapter 14 When should radiotherapy be considered for pain management and what principles should guide the consideration of limited-fraction versus full-dose radiotherapy? -- Chapter 15 When should radiopharmaceuticals be considered for pain management? |
|
Chapter 16 What principles should guide the prescribing of opioids for non-cancer-related pain? -- Chapter 17 What approaches should be used to minimize opioid diversion and abuse in palliative care? -- Chapter 18 When should epidural or intrathecal opioid infusions and pumps be considered for pain management? -- Chapter 19 When should nerve blocks be used for pain management? -- Chapter 20 What interventions are effective for managing dyspnea in cancer? -- Chapter 21 What is the role of opoids in treatment of refractory dyspnea in advanced COPD? -- Chapter 22 What nonopioid treatments should be used to manage dyspnea associated with COPD? -- Chapter 23 What interventions are effective for managing dyspnea in heart failure? |
|
Chapter 24 What medications are effective in preventing and relieving constipation in the setting of opioid use? -- Chapter 25 How should medications be initiated and titrated to reduce acute and delayed nausea and vomiting in the setting of chemotherapy? -- Chapter 26 How should medications be initiated and titrated to prevent and treat nausea and vomiting in clinical situations unrelated to chemotherapy? -- Chapter 27 What interventions are effective for relieving acute bowel obstruction in cancer and other conditions? -- Chapter 28 What medications are effective in improving anorexia and weight loss in cancer? -- Chapter 29 What therapeutic strategies are effective in improving anoerexia and weight loss in nonmalignant disease? |
|
Chapter 30 When should enteral feeding by percutaneous tube be used in patients with cancer and in patients with non-cancer-related conditions? -- Chapter 31 When should parenteral feeding be considered for patients with cancer and for patients with non-cancer-related conditions? -- Chapter 32 How does one assess for psychiatric illness in patients with advanced disease? -- Chapter 33 What treatments are effective for depression in the palliative care setting? -- Chapter 34 What treatments are effective for anxiety in patients with serious illness? -- Chapter 35 What is delirium? -- Chapter 36 What pharmacological treatments are effective for delirium? -- Chapter 37 What nonpharmacologic treatments are effective for delirium? |
|
Chapter 38 What are the differences when treating a patient at the end of life with delirium (terminal delirium)? -- Chapter 39 How do symptoms change for patients in the last days and hours of life? -- Chapter 40 What is known about prognostication in advanced or serious illness? -- Chapter 41 What is a useful strategy for estimating survival in palliative care settings for persons with advanced cancer? -- Chapter 42 What is a useful strategy for estimating survival for persons with advanced non-cancer-related illness in palliative care settings? -- Chapter 43 What are the key elements to having a conversation about setting goals and communicating serious news? -- Chapter 44 What do palliative care clinicians need to know about teaching communication? |
|
Chapter 45 What are advance care plans and how are they different than advance directives? -- Chapter 46 What elements are essential to effective advance care planning? -- Chapter 47 What is the evidence that advance care plans change patient outcomes? -- Chapter 48 What is the role for palliative care in patients with advanced cancer? -- Chapter 49 What is the clinical course of advanced cancer? -- Chapter 50 What is the relationship between patient performance status and ability to offer chemotherapeutic treatments? -- Chapter 51 What is the clinical course of advanced dementia? -- Chapter 52 What are appropriate palliative interventions for patients with advanced dementia? -- Chapter 53 What is the clinical course of advanced liver disease and what symptoms are associated with it? |
|
Chapter 54 What special considerations are needed for treating patients with chronic liver disease? -- Chapter 55 What is the Role of Palliative Care in Stroke? -- Chapter 56 What special considerations are needed for individuals with amyotrophic lateral sclerosis, multiple sclerosis, or Parkinson Disease? -- Chapter 57 What is the clinical course of advanced heart failure and how do implanted cardiac devices alter this course? -- Chapter 58 What is chronic critical illness and what outcomes can be expected? -- Chapter 59 What special considerations are needed in patients with head and neck cancer? -- Chapter 60 What special considerations are needed in treating symptoms in patients with end-stage renal disease? -- Chapter 61 How is the patient who stops dialysis best managed? |
|
Chapter 62 Which patients with end-stage renal disease should not be started on dialysis? -- Chapter 63 What is frailty? -- Chapter 64 What are the special needs of patients with frailty? -- Chapter 65 What are special considerations for treating pediatric patients and their families? -- Chapter 66 What are the signs and symptoms of spinal cord compression? -- Chapter 67 What are the best pharmacological and surgical treatments for patients with spinal cord compression? -- Chapter 68 What techniques can be used in the hospital or home setting to best manage uncontrollable bleeding? -- Chapter 69 What can be done for patients with crisis dyspnea? -- Chapter 70 What are the arguments that show that palliative care is beneficial to hospitals? |
|
Chapter 71 What are the arguments that show that outpatient palliative care is beneficial to medical systems? -- Chapter 72 What is the effect of serious illness on caregivers? -- Chapter 73 What can be done to improve outcomes for caregivers of patients with serious illness? -- Chapter 74 What is prolonged grief disorder and how can its likelihood be reduced? -- Chapter 75 What are the eligibility criteria for hospice? -- Chapter 76 In what settings can hospice be provided? -- Chapter 77 What models exist for delivering palliative care/hospice in nursing homes? -- Chapter 78 How can palliative care be integrated into home-based primary care programs? -- Chapter 79 What new models exist for ambulatory palliative care? |
|
Chapter 80 What new models exist for palliative care in the emergency department? -- Chapter 81 What are sources of spiritual and existential suffering for patients with advances disease? |
Subject |
Palliative treatment -- Miscellanea.
|
|
Evidence-based medicine -- Miscellanea.
|
|
Terminal care -- Miscellanea.
|
|
Palliative Care.
|
|
Evidence-Based Medicine.
|
|
Evidence-based medicine. (OCoLC)fst00917247
|
|
Palliative treatment. (OCoLC)fst01051719
|
|
Terminal care. (OCoLC)fst01147835
|
Genre/Form |
Miscellanea. (OCoLC)fst01423854
|
Added Author |
Goldstein, Nathan E.
|
|
Morrison, R. Sean (Rolfe Sean)
|
ISBN |
9781437737967 (pbk. ;) (alk. paper) |
|
143773796X (pbk. ;) (alk. paper) |